Stratistics MRC¿¡ µû¸£¸é ¼¼°èÀÇ ÇÁ·Î¹ÙÀÌ¿Àƽ½º ½ÃÀåÀº 2024³â¿¡ 712¾ï ´Þ·¯¸¦ Â÷ÁöÇÏ°í ¿¹Ãø ±â°£ Áß CAGR 10.2%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 1,275¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸ÁÀÔ´Ï´Ù.
ÇÁ·Î¹ÙÀÌ¿Àƽ½º´Â »ì¾ÆÀÖ´Â ¹Ì»ý¹°·Î, ÀϹÝÀûÀ¸·Î ¹ÚÅ׸®¾Æ¿Í È¿¸ðÀÔ´Ï´Ù. À¯ÀÍÇÑ ¹ÚÅ׸®¾ÆÀÇ Áõ½ÄÀ» ÃËÁøÇϰí À¯ÇØÇÑ ¹ÚÅ׸®¾ÆÀÇ Áõ½ÄÀ» ¾ïÁ¦ÇÏ¿© ±ÕÇü ÀâÈù Àå³»¼¼±ÕÃÑÀ» À¯ÁöÇÏ´Â µ¥ ±â¿©ÇÕ´Ï´Ù. ÇÁ·Î¹ÙÀÌ¿Àƽ½º´Â ¿ä±¸¸£Æ®, ÄÉÇÇ¾î µî ¹ßÈ¿½ÄǰÀ̳ª °Ç°º¸Á¶½Äǰ¿¡ ¸¹ÀÌ ÇÔÀ¯µÇ¾î ÀÖ½À´Ï´Ù. ÇÁ·Î¹ÙÀÌ¿Àƽ½º ¼·Ãë´Â ¼ÒÈ °³¼±, ¸é¿ª ±â´É °È, ƯÁ¤ À§Àå Áúȯ ¿¹¹æ µî ´Ù¾çÇÑ °Ç°»óÀÇ ÀÌÁ¡°ú °ü·ÃÀÌ ÀÖ½À´Ï´Ù.
¼¼°èº¸°Ç±â±¸(WHO)ÀÇ 2022³â º¸°í¼¿¡ µû¸£¸é À¯·´¿¡¼ ÀϺΠºñ°¨¿°¼º Áúȯ(NCDs)ÀÇ ÁÖ¿ä À§Çè ¿äÀÎ Áß Çϳª´Â ºñ¸¸À̸ç, ¼ºÀÎÀÇ 60% ÀÌ»ó, ³²ÀÚ¾ÆÀÌÀÇ 29%, ¿©ÀÚ¾ÆÀÌÀÇ 27%°¡ ºñ¸¸ÀÎ °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù.
Àå °Ç°¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ÀνÄÀÌ ³ô¾ÆÁ³½À´Ï´Ù.
Àå °Ç°¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ÀνÄÀÌ ³ô¾ÆÁö¸é¼ ÇÁ·Î¹ÙÀÌ¿Àƽ½º ½ÃÀåÀÌ Å©°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. »ç¶÷µéÀÌ ±ÕÇü ÀâÈù Àå³»¼¼±ÕÃÑÀÇ ÀÌÁ¡¿¡ ´ëÇØ ´õ ¸¹ÀÌ ¾Ë°Ô µÇ¸é¼ ÇÁ·Î¹ÙÀÌ¿Àƽ½º º¸ÃæÁ¦ ¹× ½Äǰ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼´Â ¼Òȱ⠰ǰ, ¸é¿ª·Â ¹× Àü¹ÝÀûÀÎ À£ºù¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼ ´õ¿í °¡¼Óȵǰí ÀÖ½À´Ï´Ù. °Ç° ÁöÇâÀûÀÎ ¼ÒºñÀÚµéÀº È¿°ú°¡ ÀÔÁõµÈ Á¦Ç°À» ã°í ÀÖÀ¸¸ç, ÀÌ´Â ½ÃÀå³» ±â¼ú Çõ½Å°ú Á¦Ç° Á¦°øÀÇ È®ÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÀÚ¿¬ÀûÀÌ°í ¿¹¹æÀûÀÎ °Ç°°ü¸®¿¡ ´ëÇÑ °ü½ÉÀº ´Ù¾çÇÑ °èÃþ¿¡¼ ÇÁ·Î¹ÙÀÌ¿Àƽ½ºÀÇ Ã¤ÅÃÀ» ´õ¿í °¡¼ÓȽÃ۰í ÀÖ½À´Ï´Ù.
Ç¥ÁØÈ ºÎÁ·
ÇÁ·Î¹ÙÀÌ¿Àƽ½º ½ÃÀåÀº Ç¥ÁØÈ ºÎÁ·À¸·Î ÀÎÇØ Å« ¾î·Á¿ò¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. ÀÌ ¹®Á¦´Â Áö¿ª¸¶´Ù ÇÁ·Î¹ÙÀÌ¿Àƽ½º¿¡ ´ëÇÑ ±ÔÁ¤°ú Á¤Àǰ¡ ´Ù¸£±â ¶§¹®¿¡ ǰÁú°ú È¿´É¿¡ Àϰü¼ºÀÌ ¾ø¾î ¹ß»ýÇÏ´Â ¹®Á¦ÀÔ´Ï´Ù. ±ÕÁÖ, º¹¿ë·®, °Ç° È¿´É¿¡ ´ëÇÑ Ç¥ÁØÈµÈ °¡À̵å¶óÀÎÀÌ ¾ø±â ¶§¹®¿¡ ¼ÒºñÀÚ¿Í ÀÇ·á Àü¹®°¡µé »çÀÌ¿¡ È¥¶õÀÌ ¾ß±âµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ´Ù¾çÇÑ ¶óº§¸µ ¹æ½ÄÀÌ ½ÃÀåÀ» ´õ¿í º¹ÀâÇÏ°Ô ¸¸µé°í, ¼ÒºñÀÚ°¡ Á¤º¸¿¡ ÀÔ°¢ÇÑ ¼±ÅÃÀ» ÇÒ ¼ö ÀÖ´Â ´É·ÂÀ» ÀúÇØÇϰí ÀÖ½À´Ï´Ù.
¸é¿ª·Â °È¸¦ À§ÇÑ ÇÁ·Î¹ÙÀÌ¿Àƽ½º
Àå³» ȯ°æÀÌ ¸é¿ª ±â´É¿¡ ¹ÌÄ¡´Â ¿µÇâ¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ÀνÄÀÌ ³ô¾ÆÁö¸é¼ ÇÁ·Î¹ÙÀÌ¿Àƽ½º ½ÃÀåÀÌ ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ¶ôÅä¹Ù½Ç·¯½º, ºñÇǵµ¹ÚÅ׸®¿ò µîÀÇ ±ÕÁÖ¸¦ Æ÷ÇÔÇÑ ÇÁ·Î¹ÙÀÌ¿Àƽ½º´Â Àå³»¼¼±ÕÃÑÀÇ °Ç°ÇÑ ±ÕÇüÀ» ÃËÁøÇÏ¿© ¸é¿ª ü°è¸¦ Áö¿øÇÏ°í °ÈÇϵµ·Ï °í¾ÈµÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ ±ÕÇüÀº È¿°úÀûÀÎ ¸é¿ª ¹ÝÀÀ¿¡ ¸Å¿ì Áß¿äÇϸç, °¨¿°ÀÇ ºóµµ¿Í ½É°¢¼ºÀ» °¨¼Ò½Ãų ¼ö ÀÖ½À´Ï´Ù. ¿¹¹æÀû ÇコÄɾîÀÇ Á߿伺ÀÌ °Á¶µÇ¸é¼ ÀÌ·¯ÇÑ Æ¯¼ö ÇÁ·Î¹ÙÀÌ¿Àƽ½º Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.
¾ÈÁ¤¼º ¹× º¸Á¸¼º °úÁ¦
ÇÁ·Î¹ÙÀÌ¿Àƽ½º´Â ¿Âµµ º¯È, ½Àµµ, ºû¿¡ ³ëÃâµÇ´Â µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ Àå±â°£ È¿´É°ú »ýÁ¸·ÂÀ» À¯ÁöÇϱ⠾î·Á¿î »óȲ¿¡ Á÷¸éÇÏ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. ÀÌ·¯ÇÑ Á¶°ÇÀº »ýÁ¸ °¡´ÉÇÑ ¹Ì»ý¹°ÀÇ ¼ö¸¦ °¨¼Ò½Ãų ¼ö ÀÖ½À´Ï´Ù. À¯È¿±â°£À» ¿¬ÀåÇϰí Á¦Ç°ÀÇ È¿´ÉÀ» º¸ÀåÇϱâ À§Çؼ´Â È¿°úÀûÀÎ Á¦Çü°ú Æ÷ÀåÀÌ ¸Å¿ì Áß¿äÇÕ´Ï´Ù. ÀÎĸ½¶·¹ÀÌ¼Ç ¹× º¸Á¸ ±â¼úÀÇ Çõ½ÅÀº ÀÌ·¯ÇÑ ¹®Á¦¸¦ ÇØ°áÇϰí Á¦Ç°ÀÇ ¾ÈÁ¤¼ºÀ» Çâ»ó½ÃŰ´Â °ÍÀ» ¸ñÇ¥·Î ÇÕ´Ï´Ù. µû¶ó¼ ½ÃÀå¿¡¼ ¾ÈÁ¤¼º°ú À¯Åë±âÇÑÀÇ ¹®Á¦´Â ¸Å¿ì Áß¿äÇÑ ¹®Á¦ÀÔ´Ï´Ù.
COVID-19 ÆÒµ¥¹ÍÀº ½ÃÀå¿¡ Å« ¿µÇâÀ» ¹ÌÃÄ Àå °Ç°°ú ¸é¿ª¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ÀνÄÀÌ ³ô¾ÆÁ³½À´Ï´Ù. ÆÒµ¥¹Í ±â°£ Áß »ç¶÷µéÀº ¸é¿ª ü°è¸¦ °ÈÇϰí Àü¹ÝÀûÀÎ °Ç° »óŸ¦ °³¼±Çϱâ À§ÇØ ³ë·ÂÇÏ¸é¼ ÇÁ·Î¹ÙÀÌ¿Àƽ½º¿¡ ´ëÇÑ ¼ö¿ä°¡ ´«¿¡ ¶ç°Ô ±ÞÁõÇß½À´Ï´Ù. °ø±Þ¸ÁÀÇ È¥¶õ°ú Á¦Á¶ Áö¿¬ÀÌ ¹®Á¦°¡ µÇ¾úÁö¸¸, °Ç°°ú À£ºù¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼ ½ÃÀå ¼ºÀåÀÌ °¡¼ÓȵǾú½À´Ï´Ù. ÆÒµ¥¹Í ÀÌÈÄ¿¡µµ ¿¹¹æÀû ÇコÄɾîÀÇ Ãß¼¼´Â °è¼ÓÇØ¼ ÇÁ·Î¹ÙÀÌ¿Àƽ½º ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
¿¹Ãø ±â°£ Áß ±â´É¼º ½Äǰ ºÐ¾ß°¡ °¡Àå Ŭ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
Àå °Ç°°ú À£ºù¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ±â´É¼º ½ÄǰÀº ¿¹Ãø ±â°£ Áß °¡Àå Å« ½ÃÀåÀ¸·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÇÁ·Î¹ÙÀÌ¿Àƽ½º ½ÃÀåÀÇ ±â´É¼º ½ÄǰÀº Àå °Ç°°ú Àü¹ÝÀûÀÎ À£ºùÀ» ÃËÁøÇÏ´Â »ì¾ÆÀÖ´Â À¯ÀÍÇÑ ¹ÚÅ׸®¾Æ·Î °ÈµË´Ï´Ù. ¿ä±¸¸£Æ®, ÄÉÇǾî, °Ç° º¸Á¶ ½ÄǰÀ» Æ÷ÇÔÇÑ ÀÌ·¯ÇÑ Á¦Ç°Àº ±âº»ÀûÀÎ ¿µ¾çÀ» ³Ñ¾î ƯÁ¤ °Ç°»óÀÇ ÀÌÁ¡À» Á¦°øÇÕ´Ï´Ù. ¼Òȸ¦ ÃËÁøÇϰí, ¸é¿ª ±â´ÉÀ» Áö¿øÇϸç, °ú¹Î¼º ´ëÀå ÁõÈıº°ú °°Àº Áõ»óÀ» °ü¸®ÇÏ´Â µ¥ µµ¿òÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù.
¸é¿ª °Ç° ºÐ¾ß´Â ¿¹Ãø ±â°£ Áß °¡Àå ³ôÀº CAGRÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¸é¿ª °Ç° ºÐ¾ß´Â ¿¹Ãø ±â°£ Áß °¡Àå ³ôÀº CAGRÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. À¯»ê±Õ°ú °°Àº ÇÁ·Î¹ÙÀÌ¿Àƽ½º ±ÕÁÖ´Â Àå °Ç°À» °ÈÇÏ´Â µ¥ ³Î¸® »ç¿ëµÇ¸ç, ÀÌ´Â °·ÂÇÑ ¸é¿ª ü°è¿¡ ¸Å¿ì Áß¿äÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ÇÁ·Î¹ÙÀÌ¿Àƽ½º´Â ±ÕÇü ÀâÈù Àå³»¼¼±ÕÃÑÀ» À¯ÁöÇÏ´Â µ¥ µµ¿òÀÌ µÇ¸ç, ÀÌ´Â Àü½Å ¸é¿ª·Â¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù. ¿¹¹æÀû °Ç°°ü¸®¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ÀνÄÀÌ ³ô¾ÆÁö°í À§Àå ÁúȯÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¸é¿ª ±â´ÉÀ» Áö¿øÇÏ´Â ÇÁ·Î¹ÙÀÌ¿Àƽ½º¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ´Â ½ÃÀåÀÇ Áß¿äÇÑ ¼ºÀå ºÐ¾ß¸¦ ¹Ý¿µÇϰí ÀÖ½À´Ï´Ù.
ºÏ¹Ì´Â Àå °Ç°¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ÀνÄÀÌ ³ô¾ÆÁö°í ±â´É¼º ½Äǰ ¹× º¸ÃæÁ¦¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ¿¹Ãø ±â°£ Áß °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ ½ÃÀåÀº °Ç°º¸Á¶½Äǰ, À¯Á¦Ç°, ±â´É¼º À½·á µî ´Ù¾çÇÑ Á¦Ç°±ºÀÌ Æ¯Â¡ÀÔ´Ï´Ù. ÇÁ·Î¹ÙÀÌ¿Àƽ½º ±ÕÁÖ ¹× Á¦ÇüÀÇ ¹ßÀüÀº ½ÃÀå È®´ë¸¦ ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÀÌ Áö¿ªÀÇ ÁÖ¿ä ±â¾÷Àº Á¦Ç° Á¦°øÀ» °ÈÇÏ°í ½ÃÀå Á¡À¯À²À» È®´ëÇϱâ À§ÇØ ±â¼ú Çõ½Å°ú Àü·«Àû ÆÄÆ®³Ê½Ê¿¡ ÁýÁßÇϰí ÀÖ½À´Ï´Ù.
¿¹¹æÀÇÇп¡¼ ÇÁ·Î¹ÙÀÌ¿Àƽ½ºÀÇ »ç¿ëÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¾Æ½Ã¾ÆÅÂÆò¾çÀº ¿¹Ãø ±â°£ Áß °¡Àå ³ôÀº CAGRÀ» À¯ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. °í·ÉÈ·Î ÀÎÇØ °Ç° À¯Áö ¹× Áúº´ ¿¹¹æ¿¡ ´ëÇÑ Çʿ伺ÀÌ Áõ°¡ÇÏ¸é¼ ÇÁ·Î¹ÙÀÌ¿Àƽ½º ¼Òºñ°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÁÖ¿ä ±â¾÷ÀÇ R&D ÅõÀÚ Áõ°¡´Â Á¦Ç°ÀÇ È¿´É°ú º¸±Þ·üÀ» ³ôÀÏ °ÍÀÔ´Ï´Ù. ÀϺ», Áß±¹, Àεµ µî °¢±¹ Á¤ºÎ´Â À¯¸®ÇÑ ±ÔÁ¦¿Í °¡À̵å¶óÀÎÀ» ÅëÇØ ÇÁ·Î¹ÙÀÌ¿Àƽ½º ºÐ¾ß¸¦ Áö¿øÇϰí ÀÖ½À´Ï´Ù.
According to Stratistics MRC, the Global Probiotics Market is accounted for $71.2 billion in 2024 and is expected to reach $127.5 billion by 2030 growing at a CAGR of 10.2% during the forecast period. Probiotics are live microorganisms, typically bacteria or yeast, that provides health benefits when consumed in adequate amounts. They contribute to the maintenance of a balanced gut microbiota by enhancing the growth of beneficial bacteria and inhibiting harmful ones. Probiotics are often found in fermented foods like yogurt and kefir, or as dietary supplements. Their consumption is associated with various health benefits, including improved digestion, enhanced immune function, and prevention of certain gastrointestinal disorders.
According to the World Health Organization (WHO) 2022 report, one of the major risk factors for several noncommunicable diseases (NCDs) in Europe is obesity, and over 60% of adults and 29% of boys, and 27% of girls who are children are overweight.
Rising consumer awareness of gut health
Rising consumer awareness of gut health is significantly driving the market. As people become more informed about the benefits of a balanced gut microbiome, demand for probiotic supplements and foods is increasing. This trend is fueled by growing interest in digestive health, immunity, and overall wellness. Health-conscious consumers are seeking products with proven benefits, propelling innovations and expanding product offerings in the market. The emphasis on natural and preventive healthcare further accelerates the adoption of probiotics across various demographics.
Lack of standardization
The market faces a significant challenge due to the lack of standardization. This issue arises from varying regulations and definitions of probiotics across different regions, leading to inconsistent quality and efficacy. The absence of standardized guidelines for strains, dosages, and health claims creates confusion among consumers and healthcare professionals. Moreover, the diversity in labeling practices further complicates the market, hindering the ability of consumers to make informed choices.
Probiotics for Immunity Enhancement
The market is experiencing growth due to increasing consumer awareness of gut health's impact on immune function. These probiotics, including strains such as Lactobacillus and Bifidobacterium, are formulated to support and strengthen the immune system by promoting a healthy balance of gut microbiota. This balance is crucial for an effective immune response, potentially reducing the frequency and severity of infections. The growing emphasis on preventative health measures is driving demand for these specialized probiotic products.
Stability and shelf-life challenges
Probiotics often face difficulties in maintaining potency and viability over time due to factors such as temperature fluctuations, humidity, and exposure to light. These conditions can lead to a decline in the number of viable microorganisms. Effective formulation and packaging are crucial to prolong shelf life and ensure product efficacy. Innovations in encapsulation and storage technology aim to address these challenges and enhance product stability. Thus, in the market, stability and shelf-life challenges are significant.
The COVID-19 pandemic significantly impacted the market, driving increased consumer awareness of gut health and immunity. During the pandemic, there was a notable surge in demand for probiotics as people sought to boost their immune systems and overall wellness. Disruptions in supply chains and manufacturing delays posed challenges, yet the heightened focus on health and wellness accelerated market growth. Post-pandemic, the trend towards preventive health measures continues to fuel the probiotics market's expansion.
The functional foods segment is expected to be the largest during the forecast period
The functional foods is expected to be the largest during the forecast period due to growing consumer awareness about gut health and wellness. Functional foods in the probiotics market are fortified with live beneficial bacteria that promote gut health and overall wellness. These products, including yogurt, kefir, and dietary supplements, offers specific health benefits beyond basic nutrition. They enhance digestion, support immune function, and can help manage conditions like irritable bowel syndrome.
The immune health segment is expected to have the highest CAGR during the forecast period
The immune health segment is expected to have the highest CAGR during the forecast period. Probiotic strains such as Lactobacillus are widely used to bolster gut health, which is crucial for a robust immune system. These probiotics help maintain a balanced gut microbiome, which can influence systemic immunity. Rising consumer awareness about preventive healthcare and increasing incidences of gastrointestinal disorders are driving the demand for probiotics that support immune function, reflecting a significant growth area in the market.
North America is projected to hold the largest market share during the forecast period driven by rising consumer awareness of gut health benefits and increased demand for functional foods and supplements. The market is characterized by a diverse range of products, including dietary supplements, dairy products, and functional beverages. Advances in probiotic strains and formulations are further fueling market expansion. Key players in the region are focusing on innovation and strategic partnerships to enhance product offerings and capture a larger market share.
Asia Pacific is projected to hold the highest CAGR over the forecast period owing to increasing use of probiotics in preventive healthcare. An aging demographic is driving the need for health maintenance and disease prevention, leading to increased probiotic consumption. Rising investments in research and development by key players enhance product efficacy and reach. Governments in countries like Japan, China, and India are supporting the probiotics sector with favorable regulations and guidelines.
Key players in the market
Some of the key players in Probiotics market include Danone S.A., Nestle S.A., Yakult Honsha Co., Ltd., Archer Daniels Midland Company, Procter & Gamble Co., Kerry Group plc, General Mills, Inc., Lifeway Foods, Inc., BASF SE, Royal DSM N.V., PepsiCo, Inc., Groupe Danone, Symrise AG, Wacker Chemie AG, Merck KGaA and AB Biotics SA.
In February 2024, AB Biotics SA expands its presence in Asia, partnering with Wonderlab for their globally marketed product, AB-LIFE . The collaboration introduces Shape100 , a probiotic blend focusing on cardiometabolic health, to the Chinese market. This strategic move aims to address cholesterol-related concerns through evidence-based solutions.
In November 2023, Nestle launched N3 milk, a breakthrough in nutritional innovation. Incorporating prebiotic fibers and reduced lactose, it enriches gut health and boasts over 15% fewer calories. Tailored for diverse dietary needs, N3 supports bone health, muscle growth, and immunity.